Communicating prognostic uncertainty in potential end-of-life contexts: experiences of family members [PDF]
, 2016 Background: This article reports on the concept of “communicating prognostic uncertainty” which emerged from a mixed methods survey asking family members to rank their satisfaction in seven domains of hospital end-of-life care. Methods: Open-ended
Gallagher, Romayne, Krawczyk, Marian
core +2 more sources
Frontiers in Molecular Biosciences, 2020 IntroductionTumor mutation burden (TMB) is an emerging biomarker for immunotherapy of hepatocellular carcinoma (HCC), but its value for clinical application has not been fully revealed.Materials and MethodsWe used the Wilcox test to identify the ...
Junyu Huo, Liqun Wu, Yunjin Zang
doaj +1 more source
Establishment and validation of a polygene prognostic model for clear cell renal cell carcinoma
Frontiers in Genetics, 2022 Purpose: To establish an effective prognostic model for patients with clear cell renal cell carcinoma (ccRCC).Methods: We identified four hub differentially expressed genes (DEGs) in Gene Expression Omnibus (GEO) database and verified them in the Cancer ...
Kai Gan +10 more
doaj +1 more source
Microsatellite instability, KRAS mutations and cellular distribution of TRAIL-receptors in early stage colorectal cancer. [PDF]
, 2012 Thus, we evaluated the immunofluorescence pattern of TRAIL-receptors and E-cadherin to assess the fraction of membrane-bound TRAIL-receptors in 231 selected patients with early-stage CRC undergoing surgical treatment only.
De Toni, Enrico N. +10 more
core +6 more sources
Prognosis and prognostic research: validating a prognostic model
BMJ, 2009 Prognostic models are of little clinical value unless they are shown to work in other samples.
Altman, D +3 more
openaire +4 more sources
EarlyR: A Robust Gene Expression Signature for Predicting Outcomes of Estrogen Receptor–Positive Breast Cancer [PDF]
, 2018 Introduction Early stage estrogen receptor (ER)-positive breast cancer may be treated with chemotherapy in addition to hormone therapy. Currently available molecular signatures assess the risk of recurrence and the benefit of chemotherapy; however ...
Badve, Sunil S. +2 more
core +1 more source
Clinical Utility of Circulating Tumor Cells in Patients With Esophageal Cancer
Frontiers in Oncology, 2022 BackgroundAs one of the most aggressive gastrointestinal tract cancers, esophageal carcinoma (EC) had the tenth morbidity and sixth mortality rate globally in 2020.
Yang Li +6 more
doaj +1 more source
Comparison of conservative treatment versus transcatheter arterial embolisation for the treatment of spontaneously ruptured hepatocellular carcinoma [PDF]
, 2018 Purpose: To elucidate the prognostic factors in the spontaneous rupture of hepatocellular carcinoma (HCC) and to determine whether transcatheter arterial embolisation (TAE) is associated with better prognosis compared to conservative treatment.
Baba, Yasutaka +8 more
core +1 more source
Composites Part C: Open AccessThe prognostic of the Remaining Useful Life (RUL) of composite structures remains a critical challenge as it involves understanding complex degradation behaviors while it is emerging for maintaining the safety and reliability of aerospace structures.
Ferda C. Gül +2 more
doaj +1 more source
Prognostic value of routine laboratory variables in prediction of breast cancer recurrence. [PDF]
, 2017 The prognostic value of routine laboratory variables in breast cancer has been largely overlooked. Based on laboratory tests commonly performed in clinical practice, we aimed to develop a new model to predict disease free survival (DFS) after surgical ...
Du, Ye +10 more
core +2 more sources